Inventor · disambiguated record
Antonin De Fougerolles
Also filed as: DE FOUGEROLLES ANTONIN · DE FOUGEROLLES ANTONIN R
111 granted patents·84 pending applications·4,942 citations·filing 2000–2024
99Inventor score
Files withMODERNATX INC53MODERNA THERAPEUTICS INC52ALNYLAM PHARMACEUTICALS INC25DE FOUGEROLLES ANTONIN12modeRNA Therapeutics12
Top patents by PatentIndex Score
195 records- 0199US10898574B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2018·Granted Jan 26, 2021·50 cites·10 claims
- 0299US10772975B2Modified Polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2017·Granted Sep 15, 2020·37 cites·11 claims
- 0399US10703789B2Modified polynucleotides for the production of secreted proteinsMODERNATX INC·Filed 2019·Granted Jul 7, 2020·55 cites·14 claims
- 0499US10583203B2In vivo production of proteinsMODERNATX INC·Filed 2019·Granted Mar 10, 2020·35 cites·18 claims
- 0599US10577403B2Modified polynucleotides for the production of secreted proteinsMODERNATX INC·Filed 2019·Granted Mar 3, 2020·54 cites·16 claims
- 0699US9675668B2Modified polynucleotides encoding hepatitis A virus cellular receptor 2MODERNA THERAPEUTICS INC·Filed 2013·Granted Jun 13, 2017·109 cites·14 claims
- 0799US9597380B2Terminally modified RNAMODERNATX INC·Filed 2013·Granted Mar 21, 2017·143 cites·13 claims
- 0899US9587003B2Modified polynucleotides for the production of oncology-related proteins and peptidesMODERNA THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·67 cites·19 claims
- 0999US9572896B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Feb 21, 2017·75 cites·11 claims
- 1099US9572897B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·65 cites·19 claims
- 1199US9533047B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2014·Granted Jan 3, 2017·101 cites·17 claims
- 1299US9504734B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·56 cites·19 claims
- 1399US9301993B2Modified polynucleotides encoding apoptosis inducing factor 1MODERNA THERAPEUTICS INC·Filed 2013·Granted Apr 5, 2016·89 cites·17 claims
- 1499US9303079B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Apr 5, 2016·190 cites·15 claims
- 1599US9283287B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Mar 15, 2016·84 cites·24 claims
- 1699US9254311B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Feb 9, 2016·126 cites·14 claims
- 1799US9233141B2Modified polynucleotides for the production of proteins associated with blood and lymphatic disordersMODERNA THERAPEUTICS INC·Filed 2013·Granted Jan 12, 2016·104 cites·8 claims
- 1899US9220792B2Modified polynucleotides encoding aquaporin-5MODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·101 cites·7 claims
- 1999US9220755B2Modified polynucleotides for the production of proteins associated with blood and lymphatic disordersMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·118 cites·18 claims
- 2099US9221891B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·113 cites·13 claims
- 2199US9192651B2Modified polynucleotides for the production of secreted proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Nov 24, 2015·103 cites·9 claims
- 2299US9186372B2Split dose administrationmodeRNA Therapeutics·Filed 2013·Granted Nov 17, 2015·86 cites·9 claims
- 2399US9114113B2Modified polynucleotides encoding citeD4MODERNA THERAPEUTICS INC·Filed 2013·Granted Aug 25, 2015·121 cites·15 claims
- 2499US9107886B2Modified polynucleotides encoding basic helix-loop-helix family member E41MODERNA THERAPEUTICS INC·Filed 2013·Granted Aug 18, 2015·122 cites·15 claims
- 2599US9095552B2Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1MODERNA THERAPEUTICS INC·Filed 2013·Granted Aug 4, 2015·121 cites·15 claims
- 2699US9089604B2Modified polynucleotides for treating galactosylceramidase protein deficiencyMODERNA THERAPEUTICS INC·Filed 2014·Granted Jul 28, 2015·121 cites·16 claims
- 2799US9061059B2Modified polynucleotides for treating protein deficiencyMODERNA THERAPEUTICS INC·Filed 2014·Granted Jun 23, 2015·208 cites·16 claims
- 2899US8980864B2Compositions and methods of altering cholesterol levelsMODERNA THERAPEUTICS INC·Filed 2013·Granted Mar 17, 2015·143 cites·5 claims
- 2998US12364763B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2024·Granted Jul 22, 2025·2 cites·2 claims
- 3098US11911474B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2021·Granted Feb 27, 2024·4 cites·18 claims
- 3198US10493167B2In vivo production of proteinsMODERNATX INC·Filed 2017·Granted Dec 3, 2019·26 cites·19 claims
- 3298US10286086B2Alternative nucleic acid molecules and uses thereofMODERNATX INC·Filed 2015·Granted May 14, 2019·78 cites·14 claims
- 3398US9428535B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofmodeRNA Therapeutics·Filed 2012·Granted Aug 30, 2016·113 cites·25 claims
- 3498US9149506B2Modified polynucleotides encoding septin-4MODERNA THERAPEUTICS INC·Filed 2013·Granted Oct 6, 2015·39 cites·15 claims
- 3598US9050297B2Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocatorMODERNA THERAPEUTICS INC·Filed 2013·Granted Jun 9, 2015·32 cites·17 claims
- 3698US8999380B2Modified polynucleotides for the production of biologics and proteins associated with human diseasemodeRNA Therapeutics·Filed 2013·Granted Apr 7, 2015·258 cites·16 claims
- 3798US8710200B2Engineered nucleic acids encoding a modified erythropoietin and their expressionSCHRUM JASON P·Filed 2012·Granted Apr 29, 2014·382 cites·14 claims
- 3898US8680069B2Modified polynucleotides for the production of G-CSFmodeRNA Therapeutics·Filed 2013·Granted Mar 25, 2014·180 cites·16 claims
- 3998US8664194B2Method for producing a protein of interest in a primatemodeRNA Therapeutics·Filed 2013·Granted Mar 4, 2014·90 cites·11 claims
- 4098US7737265B2RNAi modulation of HIF-1 and therapeutic uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Jun 15, 2010·122 cites·27 claims
- 4197US10501513B2Modified polynucleotides for the production of oncology-related proteins and peptidesMODERNATX INC·Filed 2017·Granted Dec 10, 2019·13 cites·12 claims
- 4297US10463751B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNATX INC·Filed 2017·Granted Nov 5, 2019·16 cites·9 claims
- 4397US10385106B2Modified polynucleotides for the production of secreted proteinsMODERNATX INC·Filed 2016·Granted Aug 20, 2019·9 cites·12 claims
- 4497US9950068B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2016·Granted Apr 24, 2018·18 cites·20 claims
- 4597US9814760B2Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2015·Granted Nov 14, 2017·15 cites·12 claims
- 4697US9512456B2Enzymes and polymerases for the synthesis of RNAMODERNATX INC·Filed 2013·Granted Dec 6, 2016·114 cites·19 claims
- 4797US9295689B2Formulation and delivery of PLGA microspheresMODERNA THERAPEUTICS INC·Filed 2013·Granted Mar 29, 2016·98 cites·9 claims
- 4897US9216205B2Modified polynucleotides encoding granulysinMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 22, 2015·15 cites·15 claims
- 4997US8754062B2DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotidesmodeRNA Therapeutics·Filed 2013·Granted Jun 17, 2014·204 cites·7 claims
- 5096US10501512B2Modified polynucleotidesMODERNATX INC·Filed 2013·Granted Dec 10, 2019·13 cites·10 claims
Showing the top 50 of 195 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Antonin De Fougerolles files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →